Hannah Gerstmyer is an undergraduate student at the University of Sydney, currently pursuing a Bachelor of Science and Advanced Studies majoring in Chemistry and Pharmacology. Her academic interests include span materials chemistry, drug design, and cheminformatics. Hannah’s current research focuses on the cheminformatics challenges posed by substances of unknown or variable composition, complex reaction products, and biological materials (UVCBs). This work aims to assist regulatory bodies such as AICIS in linking chemical structure to bioactivity. Hannah has previously contributed to the University of Sydney’s Education Innovation program, aiding in the development and implementation of a chemical biology laboratory activity designed to foster collaborative learning and student engagement. She is passionate about bridging supramolecular chemistry, data science and drug discovery and hopes to continue exploring these areas in postgraduate research.

A student at University of Adelaide, undergoing Honours of Bachelor of Health and Medical Science studies. Currently working on project regarding hepatoxicity effect and metabolic pathway of isopsoralen. Graduated from University of Adelaide, with a Bachelor of Health and Medical Science, Majoring in Medical Sciences.

Bachelor of Health and Medical Sciences(Honours) student. In 4th year of university currently and at the University of Adelaide. Currently doing a Honours project in the school of biomedicine in the discipline of pharmacology as part of University of Adelaide.

Kevin is a scientific officer at the Laboratory of Ageing and Pharmacology, Kolling Institute and the University of Sydney, led by Prof Sarah Hilmer. He leads the bioinformatics analyses of omics data to investigate the molecular mechanisms of drug-related harms in old age, aiming to understand the impact of polypharmacy whether medication cessation (deprescribing) offers any molecular reversibility benefits.

Dr. Slade Matthews is a Senior Lecturer specializing in computational pharmacology and toxicology. His research focuses on predicting chemical properties and bioactivity using Python-based QSAR models and cheminformatic techniques such as molecular fingerprinting, quantum molecular calculations, clustering, and substructure analysis. He earned his PhD in 2007 on machine learning in biomedical data and has published 48 peer-reviewed papers (Scopus h-index: 18). In 2025 Slade published a state-of-the-art graph transformer-based QSAR model for Ames mutagenicity prediction. He serves on the TGA Medical and Scientific Evaluation Services Panel and the NSW Poisons Advisory Committee both since 2010. In 2024, he was elected to the ASCEPT Board and awarded Fellowship of ACTRA in 2025. Based at the University of Sydney, Slade collaborates with academic and regulatory partners to advance public safety through application of in silico toxicology and is passionate about mentoring students and interdisciplinary research bridging chemistry, biology, and data science.

I'm Monique Stoltz - currently studying Honours Education in the Department of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University. I'm passionate about student-centered learning approaches and understanding what motivates students to engage in a subject. Outside of uni, I love animals and spending time outdoors. I'm also a massive foodie. I'm looking forward to networking with other education academics and sharing my passion for SoTL.

Kerry Watts is an expert consultant pharmacist in compounding and research, working in NSW Office for Health and Medical Research as senior officer in training, education and regulatory compliance for health system preparedness to deliver advanced therapeutics as standard of care. Kerry has recently embarked on a PhD with the University of Sydney to explore the impact of collaboration with government and academia to improve knowledge, understanding and compliance to regulation and improve patient access to advanced therapeutics

Amber Zhu is a final year medical student at University of Otago studying at the Christchurch campus. Her interests include surgery, bananagrams and medical education.

Eric Okrah obtained his master’s degree in Pharmaceutical Science from Jiangsu University, China, where his research focused on the discovery and development of anticancer agents targeting breast cancer. He later joined the Annesley Lab at La Trobe University, Australia, to pursue his PhD. Now in his third year of doctoral research, he is investigating the therapeutic potential of cannabis-derived compounds for the treatment of Parkinson’s disease. His work focuses on drug discovery, aiming to identify novel biological pathways involved in disease progression, with a particular emphasis on developing innovative therapeutics for neurological and neuropsychiatric disorders. He is especially interested in strategies that alleviate multiple pathophysiological processes and selectively target receptors and ion channels to improve drug design and efficacy.

Having moved from Darwin to study at the University of Adelaide, Aari graduated from his Bachelor of Health and Medical Sciences (Advanced) in late 2022 and its associated Honours in 2023 before commencing his PhD in Pharmacology in 2024. Aari has a broad passion for the field of pharmacology, with special interest in neuropharmacology, particularly neurodegenerative diseases and the search for disease-modifying treatments.

Cory Butlin is an Honours student at the University of Technology Sydney under the supervision of Dr Chantal Donovan and Dr Richard Kim.

William Dewar is a Bachelor of Medical Science (Honours) student at the University of Technology Sydney under the primary supervision of Dr Richard Kim and co-supervision of Dr Chantal Donovan.

Ting is a third-year PhD student at the Monash Institute of Pharmaceutical Sciences, where she has the privilege of working under the esteemed guidance of a dynamic team of researchers, including Dr. Chengxue Helena Qin, Professor Rebecca Ritchie, Associate Professor Barbara Kemp-Harper, and Dr. Peishen Elva Zhao. Her research focus is centred on unravelling the intricate regulation of formylpeptide receptors, with a particular emphasis on their role in Cardiopulmonary diseases.

Hudson is an emerging researcher who is currently an Honours student at the University of Technology Sydney under the supervision of Distinguished Professor Brian Oliver.

Jessica is a first-year PhD student at the University of Technology Sydney under the supervision of Dr Chantal Donovan and Dr Richard Kim as part of the ImmunoPharmacology Research Group.

Dr Musgrave is a molecular pharmacologist/toxicologist. He obtained his PhD from the University of Melbourne in 1989, postdoctoral work in the Institute of Pharmacology at the Free University of Berlin in 1991-1994, returning to Australia in 1994 on a CJ Martin Fellowship. He was appointed as Senior Lecturer in Pharmacology at the University of Adelaide in 2001. He has a broad interest in neuronal function and survival, natural product pharmacology and drug design. Current research focuses on the safety of herbal medicines and natural products as potential anti-amyloid medications. Ian has consulted with the State Health and the TGA on the safety of herbal medicine.

Dr Musgrave is a molecular pharmacologist/toxicologist. He obtained his PhD from the University of Melbourne in 1989, postdoctoral work in the Institute of Pharmacology at the Free University of Berlin in 1991-1994, returning to Australia in 1994 on a CJ Martin Fellowship. He was appointed as Senior Lecturer in Pharmacology at the University of Adelaide in 2001. He has a broad interest in neuronal function and survival, natural product pharmacology and drug design. Current research focuses on the safety of herbal medicines and natural products as potential anti-amyloid medications. Ian has consulted with the State Health and the TGA on the safety of herbal medicine.